Aspicio Therapeutics, Inc. — Form D
Aspicio Therapeutics, Inc. of DOWNINGTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-17. The offering totals $200K, of which $200K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2026-07-17
- Form: D
- Accession: 0002025735-26-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $200K
- Investors: 2
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-591330
Issuer
- Name: Aspicio Therapeutics, Inc.
- CIK: 0002025735
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 250 TRUMAN WAY, DOWNINGTOWN, PA, 19335
- Phone: 484.885.4744
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Michael Keane | Related Person | Downingtown, PA |
| Michael Keane | Director | Downingtown, PA |
| Michael Keane | Executive Officer | Downingtown, PA |
Other filings by this issuer (1)
More